EcoDrugPlus

Amine Oxidase Copper Containing 3

Ensembl ID : ENSCPOG00000012559
Gene Symbol: AOC3
2 Cross references
326 Possible Orthologues:

Amyloid P Component, Serum

Ensembl ID : ENSCPOG00000009766
Gene Symbol: APCS
4 Cross references
402 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSCPOG00000001427
Gene Symbol: APP
4 Cross references
279 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSCPOG00000007636
Gene Symbol: AR
2 Cross references
277 Possible Orthologues:

Angiotensin I Converting Enzyme

Ensembl ID : ENSCPOG00000001614
Gene Symbol: ACE
4 Cross references
92 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSCPOG00000007610
Gene Symbol: AGTR1
4 Cross references
213 Possible Orthologues:

Apelin Receptor

Ensembl ID : ENSCPOG00000000324
Gene Symbol: APLNR
2 Cross references
172 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSCPOG00000006509
Gene Symbol: APH1A
4 Cross references
138 Possible Orthologues:

Aph-1 Homolog B, Gamma-Secretase Subunit

Ensembl ID : ENSCPOG00000004803
Gene Symbol: APH1B
2 Cross references
193 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSCPOG00000030909
Gene Symbol: APEX1
2 Cross references
214 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s Type

Ensembl ID : ENSCPOG00000004058
Gene Symbol: ALOX12
2 Cross references
198 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSCPOG00000003939
Gene Symbol: ALOX5
4 Cross references
223 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).